Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (14%) |
| Double-patenting + other | 3 (43%) |
| Multi-statute (no §101) | 3 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ENGLISH, CONNOR KENNEDY | 1 | 60.0% | +51.3% |
| BUCCINI, MICHELLE CALLAHAN | 1 | — | — |
| HA, JULIE | 1 | 75.6% | +44.1% |
| PUTTLITZ, KARL J | 1 | 69.1% | +18.6% |
| STONEBRAKER, ALYSSA RAE | 1 | 57.9% | +50.1% |
| SKELDING, ZACHARY S | 1 | 59.8% | +41.2% |
| FISCHER, JOSEPH | 1 | 43.5% | +46.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18725704 | METHOD FOR PREPARING AND PURIFYING MONOMETHYL AURISTATIN E INTERMEDIATE | ENGLISH, CONNOR KENNEDY | — |
| 18250726 | METHOD FOR TREATING IGA NEPHROPATHY WITH TACI-FC FUSION PROTEIN | STONEBRAKER, ALYSSA RAE | — |
| 17594768 | BISPECIFIC FUSION PROTEIN AND APPLICATION THEREOF | SKELDING, ZACHARY S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18725704 | METHOD FOR PREPARING AND PURIFYING MONOMETHYL AURISTATIN E INTERMEDIATE | ENGLISH, CONNOR KENNEDY | — |
| 18374902 | PREPARATION AND PURIFICATION PROCESS OF MONOMETHYL AURISTAIN E COMPOUND | HA, JULIE | — |
| 18450966 | USE OF ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN TREATMENT OF SPECIFIC BREAST CANCER | PUTTLITZ, KARL J | — |
| 18250726 | METHOD FOR TREATING IGA NEPHROPATHY WITH TACI-FC FUSION PROTEIN | STONEBRAKER, ALYSSA RAE | — |
| 17594768 | BISPECIFIC FUSION PROTEIN AND APPLICATION THEREOF | SKELDING, ZACHARY S | — |
| 17052079 | TACI-FC FUSION PROTEINS AND USES THEREOF | FISCHER, JOSEPH | — |
| Art Unit | Apps |
|---|---|
| 1675 | 1 |
| 1654 | 1 |
| 1646 | 1 |
| 1642 | 1 |
| 1600 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18725704 | METHOD FOR PREPARING AND PURIFYING MONOMETHYL AURISTATIN E INTERMEDIATE | ENGLISH, CONNOR KENNEDY | — | §103§112 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18511869 | USE OF HER2-TARGETING ANTIBODY-DRUG CONJUGATE IN TREATMENT OF HER2-LOW EXPRESSING BREAST CANCER | BUCCINI, MICHELLE CALLAHAN | 1675 | §103§112DP | Non-Final OA | — | Pending | Nov 16, 2023 |
| 18374902 | PREPARATION AND PURIFICATION PROCESS OF MONOMETHYL AURISTAIN E COMPOUND | HA, JULIE | 1654 | §112 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18450966 | USE OF ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN TREATMENT OF SPECIFIC BREAST CANCER | PUTTLITZ, KARL J | 1646 | §103DP | Final Rejection | — | Pending | Aug 16, 2023 |
| 18250726 | METHOD FOR TREATING IGA NEPHROPATHY WITH TACI-FC FUSION PROTEIN | STONEBRAKER, ALYSSA RAE | 1642 | §102§112Other | Final Rejection | — | Pending | Apr 26, 2023 |
| 17594768 | BISPECIFIC FUSION PROTEIN AND APPLICATION THEREOF | SKELDING, ZACHARY S | 1600 | §102§103§112 | Non-Final OA | — | Pending | Oct 28, 2021 |
| 17052079 | TACI-FC FUSION PROTEINS AND USES THEREOF | FISCHER, JOSEPH | 1658 | §103DP | Final Rejection | — | Pending | Oct 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial